Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

HTNV epitope linear consecutive polypeptide and epitope peptide-compound tetramer and application

A technology of antigenic epitopes and epitope peptides, which can be used in the screening of fusion polypeptides, viral antigenic components, and compounds, and can solve the problems of non-specific prevention and treatment methods

Active Publication Date: 2017-09-08
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF8 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] Due to the high morbidity and mortality of HFRS caused by HTNV infection, but so far there is still no specific prevention and treatment method, peptide vaccine has become a new strategy for the prevention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • HTNV epitope linear consecutive polypeptide and epitope peptide-compound tetramer and application
  • HTNV epitope linear consecutive polypeptide and epitope peptide-compound tetramer and application
  • HTNV epitope linear consecutive polypeptide and epitope peptide-compound tetramer and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0042] The present invention will be further described in detail below in conjunction with specific embodiments, which are explanations of the present invention rather than limitations.

[0043] In the present invention, the HTNV-Gn / Gc CTL 9 peptide epitope with the highest affinity of HLA-A*02 in the glycoprotein Gn / Gc sequence of the HTNV 76-118 strain and its amino acid sequence are first obtained by using a T2 cell line binding test. Further, by selecting the HTNV-Gn / Gc CTL 9 peptide epitope restricted by HLA-A*02, the B cell epitope with neutralizing activity and the general Th epitope, the HTNV antigen-based epitope was designed by using computer-aided molecular design technology. Novel tandem polypeptide antigens. By designing "B+Th+CTL" epitope tandem peptides and evaluating their immunogenicity and ability to induce specific CTL responses in transgenic mice, the effectiveness and potential application of HTNV epitope tandem peptide vaccines were evaluated value.

[...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an HTNV epitope linear consecutive polypeptide. The linear consecutive polypeptide is capable of inducing the specificity T cell response to play the immune protecting effect. The invention further discloses an application of the epitope linear consecutive polypeptide for preparing polypeptide vaccine. The invention further discloses an HLA-A*02/epitope peptide-compound tetramer. The tetramer has epitope VV9 and fluorescein PE, and can be specifically bound with corresponding TCR, so the corresponding TCR can be detected by the fluorescence detection. The invention further provides a preparation method for the tetramer and an application for preparing a CTL detection reagent.

Description

technical field [0001] The invention belongs to the field of biotechnology, and particularly relates to an HTNV antigen epitope linear tandem polypeptide, an epitope peptide-complex tetramer and applications thereof. Background technique [0002] Hemorrhagic fever with renal syndrome (HFRS) is an acute infectious disease characterized by fever, hemorrhage, and severe renal impairment caused by bunyavirus Hantavirus (HTV) infection. Among the viral infectious hemorrhagic fever diseases, HFRS is the most widely distributed disease with the largest number of cases and great harm in the world. By the end of 2010, 1 893 555 cases had been reported in the world, and the mortality rate was as high as 15%. Among them, 1 585 942 cases were reported in my country, accounting for 83.75% of the total cases in the world. Hantaan virus (HTNV) is the prototype of the Hantaan virus genus, and it is also one of the important pathogenic microorganisms in the scope of verification of the prot...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00A61K39/12A61P31/14C12Q1/02
CPCA61K39/12C07K14/005C07K2319/00C12N2503/02C12N2760/12122C12N2760/12134G01N33/5038G01N33/505G01N2500/10
Inventor 马樱张赟袁斌唐康张宇丝张春梅方亮陈丽华杨琨金伯泉
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com